- Home
- TBI vs NHS Comparison
TBI vs NHS Comparison
Compare TBI & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBI
- NHS
- Stock Information
- Founded
- TBI 1985
- NHS 2003
- Country
- TBI United States
- NHS United States
- Employees
- TBI N/A
- NHS N/A
- Industry
- TBI Professional Services
- NHS Trusts Except Educational Religious and Charitable
- Sector
- TBI Consumer Discretionary
- NHS Finance
- Exchange
- TBI Nasdaq
- NHS Nasdaq
- Market Cap
- TBI 255.1M
- NHS 230.5M
- IPO Year
- TBI 1996
- NHS N/A
- Fundamental
- Price
- TBI $8.53
- NHS $7.59
- Analyst Decision
- TBI Buy
- NHS
- Analyst Count
- TBI 2
- NHS 0
- Target Price
- TBI $11.50
- NHS N/A
- AVG Volume (30 Days)
- TBI 170.3K
- NHS 111.8K
- Earning Date
- TBI 11-04-2024
- NHS 01-01-0001
- Dividend Yield
- TBI N/A
- NHS 13.44%
- EPS Growth
- TBI N/A
- NHS N/A
- EPS
- TBI N/A
- NHS N/A
- Revenue
- TBI $1,673,611,000.00
- NHS N/A
- Revenue This Year
- TBI N/A
- NHS N/A
- Revenue Next Year
- TBI N/A
- NHS N/A
- P/E Ratio
- TBI N/A
- NHS N/A
- Revenue Growth
- TBI N/A
- NHS N/A
- 52 Week Low
- TBI $6.63
- NHS $6.95
- 52 Week High
- TBI $16.14
- NHS $9.17
- Technical
- Relative Strength Index (RSI)
- TBI 59.30
- NHS 29.68
- Support Level
- TBI $8.60
- NHS $7.74
- Resistance Level
- TBI $9.05
- NHS $7.93
- Average True Range (ATR)
- TBI 0.38
- NHS 0.08
- MACD
- TBI 0.07
- NHS -0.01
- Stochastic Oscillator
- TBI 68.18
- NHS 0.00
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
About NHS Neuberger Berman High Yield Strategies Fund
Neuberger Berman High Yield Strategies Fund is closed-end management investment company. It seeks to achieve its investment objective by investing, under normal market conditions, a majority of its total assets in high yield debt securities of U.S. and foreign issuers.